MONTI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 3.346
EU - Europa 2.360
AS - Asia 1.347
SA - Sud America 181
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 7.261
Nazione #
US - Stati Uniti d'America 3.296
IT - Italia 1.067
SG - Singapore 434
CN - Cina 331
DE - Germania 327
UA - Ucraina 268
VN - Vietnam 188
SE - Svezia 166
BR - Brasile 159
HK - Hong Kong 154
TR - Turchia 115
FI - Finlandia 107
GB - Regno Unito 84
IE - Irlanda 83
FR - Francia 74
RU - Federazione Russa 73
IN - India 32
JP - Giappone 26
MX - Messico 22
ES - Italia 21
CA - Canada 19
NL - Olanda 18
BE - Belgio 17
PL - Polonia 12
BG - Bulgaria 11
ZA - Sudafrica 10
BD - Bangladesh 8
SA - Arabia Saudita 7
AT - Austria 6
CZ - Repubblica Ceca 6
IQ - Iraq 6
LT - Lituania 6
UZ - Uzbekistan 6
VE - Venezuela 6
AR - Argentina 5
MY - Malesia 5
PH - Filippine 4
AU - Australia 3
CH - Svizzera 3
CO - Colombia 3
EU - Europa 3
KZ - Kazakistan 3
PT - Portogallo 3
PY - Paraguay 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
EC - Ecuador 2
GE - Georgia 2
ID - Indonesia 2
IL - Israele 2
NG - Nigeria 2
NP - Nepal 2
PK - Pakistan 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.261
Città #
Milan 606
San Jose 283
Chandler 271
Singapore 270
Ashburn 257
Fairfield 229
Jacksonville 206
Woodbridge 162
Hong Kong 149
Ann Arbor 145
Houston 136
Como 126
Beijing 119
Dallas 109
Seattle 100
Wilmington 93
New York 92
Nyköping 87
Dearborn 86
Dublin 83
Princeton 78
Cambridge 77
Boardman 69
Los Angeles 66
Izmir 60
The Dalles 58
Rome 53
Munich 46
Lauterbourg 43
Chicago 41
Dong Ket 32
Hanoi 31
Ho Chi Minh City 29
Orem 27
São Paulo 27
Helsinki 26
San Mateo 25
Ogden 23
San Diego 19
Buffalo 17
Tokyo 17
Council Bluffs 16
Frankfurt am Main 16
London 16
Turku 16
Brussels 15
Chennai 15
Atlanta 14
Ponte Lambro 14
Santa Clara 14
Casorezzo 13
Varese 13
Denver 12
Gallarate 12
Kunming 12
Shanghai 11
Guangzhou 10
Amsterdam 9
Ankara 9
Hefei 9
Montreal 9
Poplar 9
Redmond 9
Warsaw 9
Bulgorello 8
Düsseldorf 8
Mexico City 8
Querétaro 8
Barcelona 7
Des Moines 7
Johannesburg 7
Manchester 7
Mumbai 7
San Francisco 7
Shenyang 7
Sofia 7
Washington 7
Berlin 6
Boston 6
Brooklyn 6
Da Nang 6
Nanjing 6
Paris 6
Salt Lake City 6
Charlotte 5
Edinburgh 5
Falkenstein 5
Falls Church 5
Hebei 5
Norwalk 5
Nuremberg 5
Phoenix 5
Rio de Janeiro 5
Rozzano 5
Stockholm 5
Tashkent 5
Verona 5
Baghdad 4
Bournemouth 4
Brno 4
Totale 4.969
Nome #
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis 291
AIF-1 and RNASET2 Play Complementary Roles in the Innate Immune Response of Medicinal Leech 280
In silico prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6. 235
Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase 231
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells 229
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. 226
Biochemical and immunohistochemical characterization of human RNASET2 expression 217
Intracellular trafficking of RNASET2, a novel component of P-bodies 202
A hedgehog homolog is involved in muscle formation and organization of Sepia officinalis (mollusca) mantle. 198
DYSREGULATED EXPRESSION OF ANKYRIN REPEAT DOMAIN 1 IN THE DEVELOPING MYOCARDIUM CAUSES ANOMALOUS VENOUS RETURN AND MORPHOGENETIC DEFECTS BY IMPAIRING CARDIAC REMODELLING 194
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene 192
TLR2 expression in medicinal leech 180
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 180
Cellular and biochemical characterization of the human member of Rh/T2/S ribonucleases 178
AIF-1 and RNASET2 play different roles in the modulation of leech innate immune response 178
Human RNASET2 as a candidate stress-response gene involved in non-cell autonomous tumor suppression. 177
Muscle development and differentiation in the urodele Ambystoma mexicanum. 173
RNASET2 - An autoantigen in anaplastic large cell lymphoma identified by protein array analysis. 172
Ribonuclease T2 (RNASET2) expression in the spectrum of neuroendocrine neoplasms of the lung. Relationships with hypoxia-related mechanisms and microvascular patterns 169
DIFFERENT BUT COMPLEMENTARY ROLES OF RNASET2 AND AIF-1 IN THE MODULATION OF MEDICINAL LEECHES INNATE IMMUNE RESPONSE 167
Common fragile site FRA6E spans at least 7,5 Mb 166
Prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6 166
The human RNASET2 tumor antagonizing gene as a novel stress-response gene potentially involved in microenvironment-mediated tumor suppression 166
Antimicrobial role of RNASET2 protein during innate immune response in the medicinal leech Hirudo verbana 166
Mutant alleles in Aicardi-Goutieres syndrome patients produce a disfunctional RNASET2 protein associated with alterations in interferon signalling. 161
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells 157
Molecular characterisation of human common fragile site FRA6E, a large genomic region spanning 9 Mb 149
The pleiotropic roles of the human RNASET2 tumor suppressor gene 149
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations. 145
Identification of putative cancer-related antisense transcripts in 6q21 and 6q27 143
Regionalized expression of Ankirin Repeat Domain 1 gene is essential to regulate multiple aspects of sinoatrial development and ventricular trabeculation 142
Sviluppo e differenziamento muscolare nell'urodelo Ambystoma Mexicanum 141
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene. 140
Tumor and metastasis suppression by the human RNASET2 gene. 134
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro 132
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment 122
RNASET2 is a non-cell autonomous human tumor suppressor 121
Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report 112
Recombinant HvRNASET2 protein induces a marked connective tissue remodelling in the invertebrate model Hirudo verbana 101
The alarmin-like RNASET2 molecule exerts cell-autonomous and non-cell autonomous activities in prostate cancer models 90
The human RNASET2 alarmin-like molecule differentially affects prostate cancer cells behavior in both cell autonomous and non-cell autonomous manners 88
RNASET2 is the first ribonuclease of the Rh/T2/S family discovered in humans and displays unusual roles in tumor suppression. 88
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells 86
The alarmin-like RNASET2 proteins impacts on prostate cancer (PCa) cell proliferation and inflammatory properties and shape macrophage polarization in a prostate cancer (PCa) in vivo model 81
Medicinal leeches: a promising source of cell lines with multiple biotechnological applications 76
1st International Meeting on RNA and RNases 15
The HvRNASET2 enzyme from the medicinal leech Hirudo verbana: a promising and innovative candidate for biotechnological and biomedical applications 14
Totale 7.320
Categoria #
all - tutte 26.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.251


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 0 73 81
2021/2022447 61 59 31 40 26 7 30 34 15 50 38 56
2022/2023710 64 55 46 89 44 133 7 116 91 16 32 17
2023/20241.050 145 150 142 176 215 102 15 6 32 16 16 35
2024/2025840 15 8 119 54 40 55 48 78 71 79 88 185
2025/20261.996 187 120 122 351 248 141 385 125 153 125 39 0
Totale 7.320